Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Chow S, Tang K, Al-Abri M, Hall V, et al. RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia. Leuk Res 2021;111:106735.
PMID: 34735933


Privacy Policy